Parvez Khan

Parvez Khan serves as the Gene Therapy Sales Development Leader at Cytiva, where he plays a pivotal role in advancing the capabilities of organizations involved in gene therapy. With a robust background in capital equipment sales and account management, Parvez specializes in consultative sales within the biotherapeutic manufacturing sector. His expertise extends to purification and separation processes for biologics, vaccines, and industrial biotechnology, making him a valuable asset in the rapidly evolving landscape of gene therapy.

At Cytiva, Parvez is instrumental in helping clients accelerate their gene therapy clinical pipelines by leveraging the company’s innovative products and process development services. He focuses on cGMP manufacturing platforms for viral vectors, plasmids, and non-viral vectors, ensuring that organizations can meet stringent regulatory compliance and validation requirements. His deep understanding of the pharmaceutical industry, combined with his skills in automated bioprocess systems and protein purification, allows him to provide tailored solutions that enhance operational efficiency and product quality.

In addition to his technical expertise, Parvez is adept at navigating the complexities of commercialization in the life sciences sector. His knowledge of microbiology, molecular biology, and cell culture further enriches his ability to engage with clients and address their unique challenges. By fostering strong relationships and delivering consultative support, Parvez Khan is not only driving sales growth for Cytiva but also contributing significantly to the advancement of gene therapies that hold the potential to transform patient outcomes.